|
MELK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.016200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.267800E-02 |
| Normal-vs-Stage2 |
9.563800E-01 |
| Normal-vs-Stage3 |
3.560500E-02 |
| Normal-vs-Stage4 |
1.421980E-02 |
| Stage1-vs-Stage2 |
5.80900000000106E-05 |
| Stage1-vs-Stage3 |
8.115200E-01 |
| Stage1-vs-Stage4 |
2.372800E-01 |
| Stage2-vs-Stage3 |
6.211300E-04 |
| Stage2-vs-Stage4 |
6.203100E-04 |
| Stage3-vs-Stage4 |
4.130200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.496190E-02 |
| Normal-vs-AfricanAmerican |
2.251000E-01 |
| Normal-vs-Asian |
9.243800E-02 |
| Caucasian-vs-AfricanAmerican |
3.938000E-01 |
| Caucasian-vs-Asian |
3.176600E-01 |
| AfricanAmerican-vs-Asian |
7.701200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.351800E-02 |
| Normal-vs-Female |
5.033700E-02 |
| Male-vs-Female |
5.394200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.124070E-02 |
| Normal-vs-Age(41-60Yrs) |
2.615200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.772000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.929700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.361640E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.886400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.899400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.848380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.224850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.362400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.479500E-02 |
| Classical-VS-Follicular |
2.1809999994904E-07 |
| Classical-VS-Other |
8.356400E-01 |
| Classical-VS-Normal |
1.505650E-02 |
| Tall-VS-Follicular |
1.372900E-04 |
| Tall-VS-Other |
2.846800E-01 |
| Tall-VS-Normal |
3.022000E-03 |
| Follicular-VS-Other |
1.279950E-01 |
| Follicular-VS-Normal |
9.874400E-01 |
| Other-VS-Normal |
4.034200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.280220E-01 |
| Normal-vs-N1 |
5.080400E-02 |
| N0-vs-N1 |
3.841200E-01 |
|
|
